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Purpose: To perform a phenotypic assessment of members of three British families with blue cone monochromatism
(BCM), and to determine the underlying molecular genetic basis of disease.
Methods: Affected members of three British families with BCM were examined clinically and underwent detailed
electrophysiological and psychophysical testing. Blood samples were taken for DNA extraction. Molecular analysis
involved the amplification of the coding regions of the long (L) and medium (M) wave cone opsin genes and the upstream
locus control region (LCR) by polymerase chain reaction (PCR). Gene products were directly sequenced and analyzed.
Results: In all three families, genetic analysis identified that the underlying cause of BCM involved an unequal crossover
within the opsin gene array, with an inactivating mutation. Family 1 had a single 5′-L–M-3′ hybrid gene, with an
inactivating Cys203Arg (C203R) mutation. Family 3 had an array composed of a C203R inactivated 5′-L–M-3′ hybrid
gene followed by a second inactive gene. Families 1 and 3 had typical clinical, electrophysiological, and psychophysical
findings consistent with stationary BCM. A novel mutation was detected in Family 2 that had a single hybrid gene lacking
exon 2. This family presented clinical and psychophysical evidence of a slowly progressive phenotype.
Conclusions: Two of the BCM-causing family genotypes identified in this study comprised different hybrid genes, each
of which contained the commonly described C203R inactivating mutation. The genotype in the family with evidence of
a slowly progressive phenotype represents a novel BCM mutation. The deleted exon 2 in this family is not predicted to
result in a shift in the reading frame, therefore we hypothesize that an abnormal opsin protein product may accumulate
and lead to cone cell loss over time. This is the first report of slow progression associated with this class of mutation in
the L or M opsin genes in BCM.
Blue cone (S cone) monochromatism (BCM) is a rare X-
linked  congenital  stationary  cone  dysfunction  syndrome,
affecting approximately 1 in 100,000 individuals. Affected
males  with  BCM  have  no  functional  long  wavelength
sensitive (L) or medium wavelength sensitive (M) cones in
the retina. Color discrimination is severely impaired from
birth, and vision is derived from the remaining preserved S
cones and rod photoreceptors [1,2]. BCM typically presents
with reduced visual acuity (6/24 to 6/60), pendular nystagmus,
photophobia,  and  patients  often  have  myopia.  The  rod-
specific and maximal electroretinogram (ERG) usually show
no definite abnormality, whereas the 30Hz cone ERG cannot
be detected. Single flash photopic ERG is often recordable,
albeit small and late, and the S cone ERG is well preserved
[3].  In  addition  to  electrophysiological  assessment,
psychophysical testing can be readily used to identify the
characteristic retained tritan discrimination in patients with
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BCM. These tests include the Farnsworth-Munsell 100-Hue
test, Berson color plates, Hardy, Rand, and Rittler (HRR)
plates, and the standard and enlarged Mollon-Reffin (MR)
Minimal test [4-7].
S (blue), M (green), and L (red) visual pigments confer
the different cone absorption spectra. The L and M genes in
the genomic array on Xq28 are situated in a head to tail tandem
arrangement  with  a  single  L  opsin  gene  in  a  5′  position
followed by one or more M opsin genes [1,8]. The number of
M  genes  is  polymorphic:  Approximately  25%  of  male
caucasians have a single M gene, while 50% have two M genes
and the remainder have 3 or more genes [1,8,9]. Expression
of the L and M genes is regulated by the Locus Control Region
(LCR),  a  conserved  sequence  situated  roughly  3.5  kb
upstream of the L gene. The LCR plays a critical role in
ensuring that only one opsin gene in the array is expressed in
a  single  cone  photoreceptor  [10].  It  has  also  been
demonstrated that only the first two genes of the array are
expressed in the retina [11].
The L and M cone opsins are encoded by six-exon genes,
which are highly homologous and share 96% amino acid
identity, while their homology to S cone opsin and rod opsin
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876is approximately 40% [1,8]. Seven of the 15 amino acids that
differ between the L and M opsins account for the major
differences in spectral tuning between the two photopigments.
Amino acids at positions 180, 277, and 285 have a major effect
on spectral tuning, while amino acids 116, 230, 233, and 309
confer a minor effect [12,13]. The majority of these residues
are encoded by exons 3 and 5 of the L and M opsin genes
[12,13].
The molecular genetic mechanism underlying BCM was
identified as L and M opsin gene array mutations, resulting in
nonfunctional photopigments and thus inactive L and M cones
[9,14]. The mutations identified in the L and M opsin gene
array fall into three classes. In the first class (roughly 40% of
cases), a normal L and M opsin gene array is inactivated by a
deletion in the LCR [15-17]. The second class of mutations
(approximately 60% of cases) is due to a two-step mutation
mechanism  of  nonhomologous  recombination  and  point
mutation. Nonhomologous recombination between the L and
M opsin genes reduces the number of genes in the opsin array
to one. This step is followed by a single nucleotide sequence
alteration  (point  mutation),  which  inactivates  the  residual
gene. To date, three inactivating opsin mutations (C203R,
R247X, and P307L) have been reported with C203R being
described most frequently [7,9,15]. The most common BCM
genotype in this class consists of a single inactivated L–M
hybrid gene with a C203R mutation. A third class of mutation
has been reported in a Danish BCM family where a single
opsin array gene (L) was found to have a deletion of an entire
exon (exon 4) [18].
In this study we describe a molecular genetic analysis of
the L and M opsin array in three British families with BCM
and their associated ocular phenotypes.
METHODS
Patients: This study was approved by the Moorfields Eye
Hospital Ethics Committee. Seven affected males (age range
5 years–76 years), 2 asymptomatic obligate carrier females
and one unaffected female from three British families with
BCM were examined and underwent detailed psychophysical
and electrophysiological assessment. After informed consent
was obtained, blood samples were taken. Genomic DNA was
isolated  from  whole  blood  using  an  extraction  kit  (GE
Healthcare Ltd, Buckinghamshire, UK) and molecular genetic
analysis was performed.
Clinical  assessment:  The  pedigrees  of  the  three  families
studied are shown in Figure 1. Families 2 and 3 show an
inheritance pattern consistent with X-linked inheritance. In
Family 1 the affected twins were adopted with no known
family history. A medical and ophthalmic history was taken,
and a full ophthalmological examination was performed in all
examined participants. All affected individuals were given a
full-field  electroretinogram  (ERG).  ERG  procedures
conformed  to  the  International  Society  for  Clinical
Electrophysiology of Vision standard [19], with the children
undergoing a modified protocol using skin electrodes. S cone
ERGs  were  also  recorded  in  Families  1  and  2  using  a
previously described protocol [20].
Color  vision  testing  included  the  use  of  the  Ishihara
pseudoisochromatic plates, HRR plates (American Optical
Company, New York, NY), Farnsworth-Munsell (FM) 100-
hue test, Farnsworth D-15 and enlarged Farnsworth D-15
(PV-16),  the  standard  and  enlarged  MR  test  [6],  a
computerized color vision test [21,22], and anomaloscopy.
The FM 100-hue, Farnsworth D-15/PV-16 and the MR tests
were all performed under CIE Standard Illuminant C from a
MacBeth Easel lamp.
Molecular genetic analysis: Amplification of the LCR and
exons 1 to 6 of the L and M opsin genes was undertaken in an
affected male from Families 1 to 3 (Figure 1). Subsequently
further  male  family  members  and  carrier  females  were
screened to determine segregation. Population control male
DNA samples were also used, in which we had previously
sequenced the L and M opsin genes. Since the L and M gene
sequences (exonic and intronic) are 98% identical, it was
possible to amplify the exons of both genes using one primer
pair. PCR reactions were performed to amplify a fragment
containing the LCR and to coamplify each of the six exons of
both the L and M opsin genes for each subject essentially as
previously  described  [7]  with  modifications  (primers  and
conditions  available  on  request).  PCR  reactions  (25  µl)
contained the following: 3 µl of 200 ng genomic DNA, 12.5 µl
2X Mastermix (AB-0575, Abgene, Thermo Fisher Scientific,
Leicestershire, UK), 3 µl of 2 mM forward and 3 µl of 2 mM
reverse primer and 3.5 µl dH2O. Cycling conditions were as
follows: 95 °C for 4 min followed by 35 cycles of 95 °C for
30 s, annealing temperature (Ta) °C for 30 s, 72 °C for 30 s,
followed by 1 cycle of 72 °C for 4 min. PCR products were
analyzed  by  agarose  gel  electrophoresis.  All  amplified
products were then purified enzymatically. In dH2O, 1 µl
ExoSAP-IT (GE Healthcare Ltd, Buckinghamshire, UK) was
added  to  an  aliquot  of  PCR  product  (1–6  µl  containing
approximately  500  ng)  to  create  a  volume  of  26  µl.  The
samples  were  incubated  at  37  °C  for  15  min  and  heat
inactivated at 80 °C for 15 min. An aliquot (13 µl) of purified
PCR product was then bidirectionally sequenced with 1 µl
forward or reverse primer (2 µM stock), 1 µl BigDye (version
3.1) terminator cycle sequencing chemistry, and 5 µl buffer
(Applied  Biosystems,  Warrington,  UK)  following  the
manufacturers' protocols. The product was analyzed on an
ABI 3730 Genetic Analyzer (Applied Biosystems, Applera,
UK).  The  sequence  was  examined  for  alterations  with
Lasergene DNA Star software (DNA Star Inc., Madison, WI).
Coamplification of L and M exons resulted in a mixed
population of amplified fragments, which were cosequenced.
Differentiation between L and M exons was achieved by the
identification of known sequence differences in the resultant
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877electropherograms,  conferring  different  opsin  spectral
properties, present in exons 2 to 5. Coding sequence of L and
M exons 1 and 6 were identical and could not be differentiated
on an electropherogram; however, sequence upstream of the
start codon of exon 1 contained nucleotide differences which
facilitated identification of both M and L exon 1.
To specifically amplify either L exon 2 or M exon 2, we
designed L and M gene-specific exonic primer pairs (Table
1).  PCR  and  sequencing  reactions  were  performed  as
described (see Table 1), and exon 2 gene specific products
were  successfully  amplified  and  sequenced  in  control
participants.
Long-range PCR from L exon 1 to M exon 3 in Family 2
was performed as described in this section using AB-0793
PCR Master Mix (Abgene) and an intronic coamplifying L–
M primer pair (Table 1) with a 6 min extension time and an
annealing temperature of 70 °C. The PCR fragment was then
directly sequenced with internal primers (Table 1).
RESULTS
Family 1 phenotype: Since birth, the 11-year-old twin brothers
of Family 1 (family members 2.1 and 2.2, Figure 1) were noted
to have nystagmus, but this was found to have gradually
decreased over time. The brothers complained of minimal
photophobia and reduced color vision, and were not aware of
any difficulty with night vision. One had epilepsy. They were
adopted, and no family history was known. They were both
myopic (−5.0 DS) with best corrected visual acuities of 6/24
in  both  eyes.  On  examination  they  had  mild  horizontal
pendular nystagmus, normal fundi, and clear media.
Rod-specific ERGs were normal and 30 Hz cone flicker
ERGs were undetectable in both brothers. In both brothers,
single  flash  photopic  ERGs  demonstrated  residual  cone
activity with marked delay; this was likely to be related to S
cone mechanisms, owing to the good responses recorded to
S-cone specific stimulation (S cone ERGs). Psychophysical
testing of the twins with the standard and enlarged MR test
and HRR plates revealed good discrimination along the tritan
axis and minimal residual deutan and protan discrimination.
They displayed a protan ordering of the PV-16, as has been
previously described in BCM [23]. On computerized testing
their color discrimination ellipses were oriented along the
angle  that  one  would  expect  of  someone  making  color
discriminations based on a comparison of quantum catches in
the rods and S-cones.
Family 1 genotype: Sequence analysis in family member 2.1
revealed  no  deletions  or  sequence  variants  of  the  LCR.
Sequence representing exons 1, 2, and 3 of the L gene was
identified, while exons 4 and 5 of the L gene were absent
(Figure 2). Exons 1, 4, and 5 of the M gene were present, but
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Figure  1.  BCM  family  pedigrees.
Affected  males  are  represented  by
shaded boxes. Obligate female carriers
are represented by circles with a central
black dot. In Family 1 the affected twins
were  adopted  with  no  known  family
history  of  BCM  (represented  by  “?”
symbol). The pedigrees of Families 2
and  3  show  an  X-linked  pattern  of
inheritance.M exons 2 and 3 were absent (Figure 2). The first gene in the
array is therefore a 5′-L–M-3′ hybrid gene comprising L exons
1, 2, and 3 joined to M exons 4, 5, and 6 (Figure 3). Alignment
of the hybrid gene with wild-type M and L sequence showed
that this opsin gene carries a T>C nucleotide substitution in
exon 4, encoding the Cys203Arg missense mutation (C203R)
which is known to disrupt the folding of cone opsin (Figure
2D). Individual 2.2 was also found to have the same genotype.
Although the coding region sequences of exons 1 and 6
were identical in the L and M genes, nucleotide variation
between the L and M sequences in the noncoding upstream
region of exon 1 was detected, indicating that both L and M
copies of exon 1 were present in affected members of the
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TABLE 1. PCR PRIMERS USED TO FURTHER ANALYZE THE OPSIN ARRAY IN FAMILY 2.
L or M opsin specific exon 2 PCR primers 5′-3′ Sequence Product size
 Annealing
temperature
   (Ta) °C
LEx2F ctggatgatctttgtggtcac 192 base pairs (bp) 59
LEx2R cccagcacgaagtagccag
MEx2F ctggatgatctttgtggtcat 192 bp 56
MEx2R cccagcacgaagtagccat
Long Range PCR primers 5′- 3′ Sequence Product size Ta °C
LRF ggctgcactgggggccac ~7–8 kilobases 70
LRR aagcaaagcttcccactgtcctgcttagac
Internal opsin sequencing primers                    5′- 3′ Sequence
Mint1F tttctcacagctctggaggc
Mint2R agggagacaggcctaca
Long wave sensitive (L) and Medium wave sensitive (M) opsin specific primer pairs were designed to independently amplify
L or M exon 2 sequences. Primer pair LEx2F and LEx2R (Long wave sensitive Exon 2 Forward and Long wave sensitive Exon
2 Reverse) was used to amplify L exon 2 sequence only while primer pair MEx2F and MEx2R was used to amplify M exon 2
sequence only. The Long Range PCR primers (Long Range Forward [LRF] and Long Range Reverse [LRR]) were designed to
co-amplify L and M gene sequence spanning the suspected hybrid gene deletion of exon 2 in Family 2. Internal opsin sequencing
primers M gene intron 1 Forward (Mint1F) and M gene intron 2 Reverse (Mint2R) were designed to sequence the 7.5 kb PCR
product amplified by the Long Range PCR primer pair.
Figure 2. Sequence analysis of L and M
opsin genes in Family 1. Sequence from
an  affected  male  (2.1)  was  generated
with primers designed to coamplify both
L and M genes. Reference sequences of
the L and M genes are shown on top of
the  patient  electropherograms.
Nucleotides  marked  with  an  arrow
indicate known differences between the
L and M genes or a patient mutation. A
shows  electropherogram  sequence  in
the region of exon 1 5′ to the start codon
(indicated by capital letters). Note the
double peaks (denoted N) at positions of
sequence  variation  between  L  and  M
genes (arrows), indicating the presence
of  both  L  and  M  exon  1.  B  shows
sequence from Exon 3. Single peaks at
positions of known nucleotide variation
(arrows) between the L and M genes
indicate only L opsin exon 3 is present.
C  shows  an  electropherogram  from
Exon  4  which  indicates  M  exon  4
sequence  only  is  present.  D  shows  a
section  of  Exon  4  in  which  a  T>C
nucleotide  substitution  (arrow)  is
present that results in a C203R missense
mutation.family (Figure 2A). This suggests that there is a second gene
in the array with an M exon 1. Possible structures of this
second gene are shown in Figure 3. All possible second genes
were predicted to be inactive. The C203R mutation will be
present in all genes in the array with an exon 4, as there is no
wild-type exon 4 sequence (Figures 2C,D). In summary, BCM
in Family 1 is due to a two-step mutational mechanism in
which non homologous recombination has been followed by
an inactivating point mutation. In this case, step one resulted
in the formation of a 5′-L/M-3′ hybrid gene and step two
resulted in inactivation of the hybrid by a missense C203R
mutation in M exon 4. Although a second gene may be present
in the array, this would also be non-functional owing either to
the presence of the C203R missense mutation in M exon 4 or
to a deletion.
Family 2 phenotype: The detailed phenotype of this extended
family has been previously reported [7]. In brief, both family
member 3.1, age 12, and family member 3.3, age 7, had typical
clinical  features  of  BCM,  with  normal  fundi.  On
electrophysiological testing, both had absent cone responses
but normal rod responses. Detailed psychophysical testing
revealed reasonable discrimination only along the tritan axis
in both participants.
Their 60-year-old affected grandfather (1.1) complained
that his vision had continued to slowly deteriorate throughout
life. He had evidence of mild bilateral macular retinal pigment
epithelial changes. Cone ERG responses were absent, but rod
responses were normal; he had no residual color vision.
Since  3.1  and  3.3  both  had  good  tritan  color
discrimination  and  their  grandfather  had  no  color
discrimination, it would appear that their condition is not
stationary. Both 3.1 and 3.3 had a typical BCM phenotype,
whereas their grandfather behaved as a rod monochromat,
presumably as a result of S cone loss. The lack of color vision
seen in the grandfather is highly unlikely to be due to lenticular
changes since his lenses were found to be clear.
Family  2  Genotype:  In  a  previous  study,  the  underlying
molecular cause of BCM in this family was not detected [7].
In the current study, no sequence variants or deletions were
identified  in  the  LCR  in  family  member  1.1.  Sequence
analysis demonstrated the presence of a single gene in the
array (Figure 4). Only L exon 1 sequence was detected, and
only M exons 3, 4, and 5 were present, indicating the gene is
a 5′-L–M-3′ hybrid gene (Figure 3 and Figure 4). Exon 2 failed
to  amplify  in  family  member  1.1  with  a  primer  pair  that
coamplifies  both  L  and  M  exon  2,  indicating  a  possible
deletion of exon 2. To test for the absence of an L or M exon
2, we designed specific primer pairs to the L or M gene (Table
1). The primer sequences for L exon 2 and M exon 2 were
created to encompass sequence differences between the two
genes to specifically amplify either L derived or M derived
exon 2 (Table 1). As the primer pair that coamplifies both L
and  M  exon  2  was  intronic,  it  was  plausible  that  family
member 1.1 had a polymorphism at the primer annealing site
which caused the PCR reactions to fail. However, no L or M
exon 2 was detected with L or M specific primers (Table 1
and Figure 5) thereby suggesting that family member 1.1 had
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Figure 3. Diagram representing BCM
genotypes of the 3 British families. The
wild type L-M opsin gene array is shown
at  the  top  of  the  figure.  Grey  boxes
represent  L  opsin  exons,  and  white
boxes  represent  M  opsin  exons.
Subscript n represents one or more M
opsin genes. The black box represents
the Locus Control Region (LCR). The
LCR was present without mutation in all
three  families.  The  C203R  point
mutations  detected  in  Family  1  and
Family  3  are  shown  above  the
corresponding exons. Family 1 has an
inactive  hybrid  gene  followed  by  a
second gene in the array. Three possible
structures of this second inactive gene
are shown in the bracket. Family 2 has a
single  nonfunctional  hybrid  gene
lacking exon 2. Family 3 has a single
inactive hybrid gene.a deletion of exon 2. Family members 3.1 and 3.3 were also
found to have the same genotype and a lack of L or M exon
2. Long range PCR from L exon 1 to M exon 3 (Table 1) and
subsequent direct sequencing resulted in identification of the
deletion breakpoint (Figure 5). The deletion spans intron 1 and
exon 2 and removes 1,207 bp from the hybrid opsin gene
sequence including the splice acceptor for exon 2 and the
majority of exon 2 coding sequence (Figure 5). Only 9 bp of
exon 2 remained. In summary, BCM in Family 2 is due to
nonhomologous  recombination  resulting  in  a  5′-L–M-3′
hybrid gene which is rendered inactive by a novel deletion of
exon 2 (Figure 3 and Figure 5).
Family 3 Phenotype: The affected subjects (4.2 and 2.3), age
13 and 65 years respectively, had typical clinical features of
BCM  and  normal  myopic  fundi.  Family  member  4.2
underwent electrophysiological assessment, which revealed
absent cone responses but normal rod responses. Both had
reduced visual acuity with their myopic correction: family
member 2.3 had a visual acuity of 6/36 in both eyes and family
member 4.2 had a visual acuity of 6/36 right, 6/24 left. Family
member 4.2 also underwent detailed psychophysical testing.
With the standard and enlarged MR test and HRR plates, good
tritan  discrimination  was  detected.  He  displayed  a  protan
ordering of the D-15, as has been previously described in
BCM [24]. On computerized testing, he showed no evidence
of  color  vision  on  the  protan  or  deutan  axis  but  good
discrimination along the tritan axis.
Family 3 Genotype: No sequence variants or deletions were
identified in the LCR. Sequence analysis demonstrated the
presence of L exon 1 and 2, and M exon 3, 4, and 5 only (Figure
6) as a single hybrid 5′-L–M-3′ gene (Figure 3). The sequence
results, which indicated the presence of only L exon 2 in this
family, were confirmed by specific exon 2 amplification as
described for Family 2. Figure 5 shows that family member
2.3 (sample F3) had L exon 2 (Figure 5A) but no M exon 2
(Figure 5B). Sequence analysis of exon 4 revealed that this
hybrid  opsin  gene  carries  a  T>C  nucleotide  substitution,
encoding a C203R missense mutation (Figure 6E and Figure
2D). Family member 4.2 was also found to have the same
genotype. In contrast to Family 1, the hybrid opsin gene in this
family consisted of L exons 1 and 2 joined to M exons 3 to 6,
indicating that nonhomologous intragenic recombination took
place between L exon 2 and M exon 3 (Figure 3). In summary,
BCM  in  Family  3  is  also  due  to  a  two-step  mutational
mechanism  where  nonhomologous  recombination  has
resulted in a 5′-L–M-3′ hybrid gene that is rendered inactive
by a C203R missense mutation in exon 4 (Figure 3, Figure 5,
and Figure 6).
DISCUSSION
We have identified the molecular genetic basis of BCM in
each of the three families described, with one family harboring
a  novel  disease-causing  genotype.  In  all  cases  genetic
rearrangements of the L and M opsin array were found that
would result in a lack of functional L and M pigments, and
thus  inactivate  the  corresponding  cones.  The  genetic
mechanism leading to BCM in two of these families requires
a  two-step  pathway  of  nonhomologous  recombination
followed by an intragenic mutation. In family 2 the single
hybrid gene lacking exon 2 is likely to have occurred by a
single nonhomologous recombination event. Two out of the
3 families (Families 2 and 3) had a single hybrid gene in the
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Figure 4. Sequence analysis of L and M
opsin  genes  in  Family  2.  Reference
sequences  of  the  L  and  M  genes  are
shown on top of the electropherograms,
which were generated from an affected
male  (individual  1.1)  in  Family  2.
Nucleotides  marked  with  an  arrow
indicate known differences between the
L and M genes. A shows opsin sequence
beginning 5′ to the start codon (capital
letters) of exon 1. Note the presence of
single  sequence  peaks  at  positions  of
known nucleotide variation between L
and  M  gene  sequences  (arrows),
indicating the absence of M exon 1. B
shows  Exon  3  sequence  with  single
peaks  at  sites  of  known  variation
between L and M opsin gene sequences
(arrows) representing the presence of M
exon  3  nucleotides  and  absence  of  L
exon 3 nucleotides. Similarly, absence
of an L sequence was noted for exons 4
and 5 (data not shown).array that was inactivated either by a point mutation (C203R
in Family 3) or by a deletion (exon 2 in Family 2). In the
remaining family (Family 1), the array is probably composed
of a hybrid gene adjacent to a second gene (either an M gene
or  a  second  hybrid),  both  of  which  are  nonfunctional.
Inactivation of the genes in this array is due either to the
presence of a C203R mutation in the first two genes of the
array or to a C203R substitution in the first and the deletion
of several exons in the second.
The C203R mutation has been identified previously in
several  molecular  genetic  studies  of  BCM  [7,9,15].  The
C203R substitution destabilizes the L and M opsin proteins
by disrupting a highly conserved disulphide bond which plays
a crucial role in the tertiary structure of both rod and cone
opsins [23]. We identified this inactivating mutation in two
out of the three families, thereby providing further evidence
that C203R is the most frequent point mutation in BCM. Four
British families are now known to harbor the C203R mutation.
There are no reports of LCR deletions in this population [7,
and this article]. As more families are diagnosed clinically and
the molecular basis of disease is defined, it will be interesting
to see if this reflects a population difference in mutational
mechanism, compared with, for example, the United States
patient population, in whom LCR deletions have been found
in up to 40% of cases [9,15-17].
The genotype identified in Family 2 of a single hybrid
gene  inactivated  by  a  lack  of  exon  2  represents  a  novel
mutation resulting in BCM. The only previously reported
similar class of mutation was in a Danish family in whom exon
4 of a single L opsin gene had been deleted [18]. This therefore
represents the second example of an uncommon category of
BCM mutations that involves an intragenic exonic deletion in
a single gene in the array. Interestingly, the exon 4 deletion in
the  Danish  family  is  predicted  to  result  in  a  frameshift
mutation by splicing exon 3 to exon 5, which would alter the
reading  frame  of  the  L  cone  opsin  gene  and  generate  a
truncated protein with a premature stop at codon 266 [18]. It
is possible that this frameshift mutation would be subject to
nonsense mediated mRNA decay. In direct contrast, the novel
exon 2 deletion we detected in Family 2 would not result in a
shift of the reading frame. Instead, it is predicted that exon 1
is spliced in-frame to exons 3–6 and a protein product may be
Molecular Vision 2009; 15:876-884 <http://www.molvis.org/molvis/v15/a91> © 2009 Molecular Vision
882
Figure 5. Analysis of the hybrid gene in
Family 2. A and B show agarose gel
photographs of PCR products (192 bp)
obtained using primer pairs (Table 1)
specifically designed to amplify either L
exon 2 (A) or M exon 2 (B). Individual
1.1 of Family 2 is represented by sample
F2  on  the  gels.  No  amplification
products were obtained for sample F2
with either L opsin gene specific primers
(A) or M opsin gene specific primers
(B), indicating absence of exon 2 of both
L  and  M  opsin  genes  in  Family  2.
Sample  F3  represents  subject  2.3  of
Family  3,  who  has  a  hybrid  gene  in
which L exon 2 is present (A) but M
exon 2 (B) is absent. These data confirm
the absence of both L and M exon 2 in
sample  F2  (1.1  Family  2)  and  the
presence of L exon 2 and absence of M
exon 2 in sample F3 (2.3 Family 3). C
denotes male population control sample.
Dash  (–)  denotes  a  DNA  negative
control sample, and M indicates a 100
bp DNA ladder. C shows sequence of
individual 1.1 in Family 2 in which the
deletion breakpoint within exon 2 was
detected.  The  subject  sequence  was
compared  to  the  wild  type  (WT)
reference sequence demonstrating that
the majority of exon 2 is deleted; intron
1 sequence was joined to terminal exon
2  sequence  with  2  bp  of  intervening
sequence.generated. The protein would be nonfunctional as exon 2
codes for a major part of the opsin. The mutant protein product
would  lack  part  of  the  N-terminal  extracellular  domain,
transmembrane helix I, cytoplasmic loop I, transmembrane
domain II, extracellular loop I and part of transmembrane
helix III. We hypothesize that this mutant partial “opsin”
protein could accumulate in L and M cone photoreceptors that
express this hybrid gene product over time, leading to gradual
cone cell loss and a slowly progressive phenotype as observed
in Family 2.
In addition to Family 2 there are a small number of other
families with BCM in which slow disease progression has
been documented [7,9,17,25]. Molecular genetic studies in
three of the families have shown an LCR deletion in two
families [9,17] and a single L–M hybrid with an inactivating
C203R mutation in the third family [7]. Progression was not
reported in the Danish family in whom exon 4 of an isolated
L opsin gene had been deleted [18]. Our findings in Family 2
provide  further  evidence  of  intragenic  heterogeneity  even
among families with a slowly progressive BCM phenotype. It
is difficult to postulate a molecular mechanism underlying
disease progression in the families with either LCR deletions
or single inactive hybrid genes. These genotypes are the most
commonly  identified  mutants  in  BCM,  yet  most  of  the
affected  individuals  in  these  families  have  a  stationary
disorder. It is possible, however, that unidentified modifying
genes or environmental factors may account for this observed
phenotypic  heterogeneity.  It  is  also  probable  that  if  more
detailed phenotyping, including psychophysical testing, were
employed over time in more patients with BCM, progression
might be detected more commonly than expected.
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